Takeda Pharmaceutical Co Ltd

UBS Group AG TAK
Report date
3/31/2026
Quarter
2026 Q1
Filed
5/5/2026
Shares
2,740,229
Value ($000)
50,749
Weight
0.0%
2019 Q4 - 2026 Q1 (26 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).